KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Non-cash Items (2018 - 2025)

ClearPoint Neuro's Non-cash Items history spans 11 years, with the latest figure at $1.3 million for Q3 2025.

  • For Q3 2025, Non-cash Items changed N/A year-over-year to $1.3 million; the TTM value through Sep 2025 reached $1.3 million, changed N/A, while the annual FY2024 figure was $1.3 million, N/A changed from the prior year.
  • Non-cash Items for Q3 2025 was $1.3 million at ClearPoint Neuro, down from $1.3 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $21.5 million in Q1 2021 and bottomed at $1.3 million in Q4 2024.
  • The 3-year median for Non-cash Items is $1.3 million (2025), against an average of $6.3 million.
  • The largest YoY upside for Non-cash Items was 4927.1% in 2021 against a maximum downside of 176.64% in 2021.
  • A 3-year view of Non-cash Items shows it stood at $15.3 million in 2021, then tumbled by 91.83% to $1.3 million in 2024, then increased by 2.1% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Non-cash Items are $1.3 million (Q3 2025), $1.3 million (Q2 2025), and $1.3 million (Q1 2025).